One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2018-99-112079
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 8 |
Affiliation: National and Kapodistrian University of Athens, University Children's Hospital Tübingen, University Hospital Heidelberg, Heidelberg University, National Center for Tumor Diseases, Nagoya City University, National University Health System, National University Cancer Institute, Singapore, Amsterdam University Medical Centers, Millennium Engineering and Integration (United States), Takeda (United States), Mayo Clinic, Medical University of Lodz, Institute of Cancer Research, University of Arkansas for Medical Sciences, Oslo University Hospital, Ankara University, University Hospital Ostrava, Centro de Investigación del Cáncer, Seoul St. Mary's Hospital, University of Hradec Králové
Maintenance Therapy with the Oral Proteasome Inhibitor (PI) Ixazomib Significantly Prolongs Progression-Free Survival (PFS) Following Autologous Stem Cell Transplantation (ASCT) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Phase 3 Tourmaline-MM3 Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
